Twist Bioscience Corp - 8-K Filing
Twist Bioscience reports Q3 FY2026 revenue of $118.4M (+23% YoY), raises full-year guidance and reiterates adjusted EBITDA breakeven in Q4.
Tickers: $TWST
More Regulatory news
- Solana Co - 10-Q Filing
- Solana Co - 8-K Filing
- DeFi Development Corp. - 8-K Filing
- Stablecoin Development Corp - 8-K Filing
- BCP Investment Corp - 8-K Filing
- OneWater Marine Inc. - 8-K Filing
- Moleculin Biotech, Inc. - 8-K Filing
- Investcorp Credit Management BDC, Inc. - 8-K Filing
- Presurance Holdings, Inc. - 10-Q Filing
- Corteva, Inc. - 8-K Filing